Go Pro
→ Porter flew 3,300 miles to investigate this system (From Porter & Company) (Ad)tc pixel Free IMUX Stock Alerts

Immunic (IMUX) News Today

Immunic logo
$13.11 +0.35 (+2.74%)
As of 09/4/2026 04:00 PM Eastern
Compare

Immunic Latest News

Braidwell LP Invests $9.91 Million in Immunic, Inc. $IMUX
September 3 at 4:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-braidwell-lp-invests-991-million-in-immunic-inc-imux-2026-09-03/
Immunic to host virtual relapsing MS R&D Day on September 9
September 2 at 8:54 AM  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1097985?snapi
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
September 2 at 6:30 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-to-host-virtual-relapsing-multiple-sclerosis-rd-day-on-september-9-2026-302862414.html
Immunic Appoints Chitrang Davé as Chief Data and Digital Officer
September 1, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-appoints-chitrang-dave-as-chief-data-and-digital-officer-302864930.html
Immunic (IMUX) Stock Forecast & Price Target
August 27, 2026  |  investing.comhttps://www.investing.com/equities/vital-thera-consensus-estimates
Immunic: Potent Under-The-Radar MS Lineup Set For A Rerating
August 25, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4939984-immunic-potent-under-the-radar-ms-lineup-set-for-a-rerating
Immunic, Inc. (NASDAQ:IMUX) Receives Consensus Rating of "Buy" from Analysts
August 25, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30981760
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Buy" by Brokerages
August 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/immunic-inc-nasdaqimux-given-average-rating-of-buy-by-brokerages-2026-08-20/
Wedbush Begins Coverage on Immunic (NASDAQ:IMUX)
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wedbush-begins-coverage-on-immunic-nasdaqimux-2026-08-17/
Immunic Q3 EPS Boosted by Brookline Capital Markets
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/immunic-q3-eps-boosted-by-brookline-capital-markets-2026-08-17/
HC Wainwright Predicts Immunic's Q3 Earnings (NASDAQ:IMUX)
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-predicts-immunics-q3-earnings-nasdaqimux-2026-08-17/
Renaissance Technologies LLC Invests $1.02 Million in Immunic, Inc. $IMUX
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-invests-102-million-in-immunic-inc-imux-2026-08-15/
Immunic (NASDAQ:IMUX) Upgraded to "Hold" at Wall Street Zen
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/immunic-nasdaqimux-upgraded-to-hold-at-wall-street-zen-2026-08-15/
Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS) and Immunic (IMUX)
August 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/KRYS/pressreleases/3831711/analysts-offer-insights-on-healthcare-companies-krystal-biotech-krys-and-immunic-imux/
Immunic CEO on Q2 progress and Phase 3 MS trial milestones
August 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/video/immunic-ceo-q2-progress-phase-190717973.html
Immunic (NASDAQ:IMUX) Issues Quarterly Earnings Results, Beats Estimates By $0.36 EPS
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/immunic-nasdaqimux-issues-quarterly-earnings-results-beats-estimates-by-036-eps-2026-08-11/
Immunic advances MS drug toward key Phase 3 data, expects results by year-end
August 11, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1096872?snapi
Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-inc-reports-second-quarter-2026-financial-results-and-provides-corporate-update-302847353.html
Immunic Appoints Elena Ridloff to Board of Directors
August 10, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-appoints-elena-ridloff-to-board-of-directors-302847098.html
Immunic to Participate in Investor Conferences in July
July 9, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-to-participate-in-investor-conferences-in-july-302821082.html
Immunic Expands Equity Plan and Reelects Board Directors
June 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/immunic-expands-equity-plan-and-reelects-board-directors?utm_source=marketbeat.com&utm_medium=referral
Immunic Adds Veteran Biopharma Leader to Board
June 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/IMUX/pressreleases/1093192/immunic-adds-veteran-biopharma-leader-to-board/
Immunic to Participate in Investor, Industry and Scientific Conferences in June
June 10, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-to-participate-in-investor-industry-and-scientific-conferences-in-june-302796034.html
Immunic presents new vidofludimus calcium data at multiple sclerosis conference
May 28, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1093057?snapi
Immunic Highlights Positive Phase 2 CALLIPER MS Data
May 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/immunic-highlights-positive-phase-2-calliper-ms-data?utm_source=marketbeat.com&utm_medium=referral
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
May 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-to-present-additional-phase-2-calliper-trial-data-for-vidofludimus-calcium-at-the-cmsc-annual-meeting-2026-reinforcing-its-potential-in-progressive-multiple-sclerosis-302784119.html
Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials
May 27, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1092967?snapi
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
May 27, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-appoints-distinguished-biopharmaceutical-executive-erik-lundgren-as-chief-executive-officer-302782595.html
Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout
May 19, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1092532?snapi
Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX) and Immunic (IMUX)
May 19, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2005149/analysts-offer-insights-on-healthcare-companies-avalo-therapeutics-avtx-and-immunic-imux/
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
May 19, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-appoints-seasoned-biopharmaceutical-executive-michael-w-bonney-as-chair-of-the-board-of-directors-302774994.html
Immunic (IMUX) Gets a Buy from LifeSci Capital
May 18, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/1998209/immunic-imux-gets-a-buy-from-lifesci-capital/
Is Immunic (NASDAQ:IMUX) In A Good Position To Deliver On Growth Plans?
May 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/immunic-nasdaq-imux-good-position-143141130.html
Immunic advances Phase 3 MS program, eyes topline data by year-end
May 13, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1092217?snapi
Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-inc-reports-first-quarter-2026-financial-results-and-provides-corporate-update-302769899.html
Immunic: Saved By A 200 Million Private Placement
May 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4903109-immunic-saved-by-a-200-million-private-placement
Analysts Offer Insights on Healthcare Companies: Immunic (IMUX) and Hinge Health, Inc. Class A (HNGE)
May 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HNGE/pressreleases/1757401/analysts-offer-insights-on-healthcare-companies-immunic-imux-and-hinge-health-inc-class-a-hnge/
Immunic to Participate in Investor and Medical Conferences in May
April 30, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-to-participate-in-investor-and-medical-conferences-in-may-302758603.html
Immunic Appoints Veteran Neurology Leader as Chief Medical Officer
April 30, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/IMUX/pressreleases/1586336/immunic-appoints-veteran-neurology-leader-as-chief-medical-officer/
Immunic (IMUX) price target increased by 920.41% to 54.64
April 28, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/immunic-imux-price-target-increased-by-920-41-to-54-64/ar-AA21V2ye
Immunic appoints Michael Panzara as CMO ahead of pivotal MS drug readout
April 28, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1091334?snapi
Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D.
April 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-appoints-accomplished-biopharmaceutical-executive-michael-a-panzara-md-mph-as-chief-medical-officer-302755439.html
Immunic Shareholders Approve Reverse Stock Split Initiative
April 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/IMUX/pressreleases/1499897/immunic-shareholders-approve-reverse-stock-split-initiative/
Immunic to implement 1-for-10 reverse stock split
April 23, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1091073?snapi
Immunic, Inc. Announces 1-for-10 Reverse Stock Split
April 23, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/immunic-inc-announces-1-for-10-reverse-stock-split-302747385.html
Stifel initiates coverage of Immunic (IMUX) with buy recommendation
April 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/stifel-initiates-coverage-of-immunic-imux-with-buy-recommendation/ar-AA219sKs
Immunic's next-gen oral multiple sclerosis drug poised to capture share, analyst says
April 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/general/immunic-s-next-gen-oral-multiple-sclerosis-drug-poised-to-capture-share-analyst-says/ar-AA218SeH
Immunic, Inc. (IMUX) Presents at 8th Annual Neuroimmunology Drug Development Summit - Slideshow
April 16, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4891329-immunic-inc-imux-presents-at-8th-annual-neuroimmunology-drug-development-summit-slideshow
D Boral Capital downgrades Immunic (IMUX)
April 16, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/d-boral-capital-downgrades-immunic-imux/ar-AA20YF1e
Immunic Sets 1-for-10 Reverse Stock Split Plan
April 14, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/immunic-sets-1-for-10-reverse-stock-split-plan?utm_source=marketbeat.com&utm_medium=referral

Immunic Media Mentions By Week

Immunic Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMUX
News Sentiment
▼
0.36

0.77
▲
Average
Healthcare
News Sentiment

Immunic News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMUX Articles
This Week
▼
4

4
▲
IMUX Articles
Average Week

Immunic Trends on MarketBeat

This week vs. last week
New Followers
1
-67%
Searches
5
-17%
Page Views
4,022
+14%
Get Immunic News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMUX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Immunic dated 9/3/2026.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel